Filed: 11/14/2024ACC: 0001012975-24-000476
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $260.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$260.56M
Total AUM (reported)
32.58M
Total Shares
Allocation by class
COM$256.96M98.6%
COM NEW$3.46M1.3%
CLASS A COM$134.8K0.1%
Portfolio Concentration
Top 3$225.00M86.4%
4–10$35.57M13.6%
Top 3 weight
86.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 32.58M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
32.58M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings9
Rows:
BEAM THERAPEUTICS INC.
SOLEShares4.83M
TypeSH
Market value$118.45M
45.46%
Sole
0.00
Shared
0.00
None
4.83M
RAPPORT THERAPEUTICS, INC.
SOLEShares3.73M
TypeSH
Market value$76.36M
29.31%
Sole
0.00
Shared
0.00
None
3.73M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$30.18M
11.58%
Sole
0.00
Shared
0.00
None
11.06M
Q32 BIO INC.
SOLEShares320.48K
TypeSH
Market value$14.30M
5.49%
Sole
0.00
Shared
0.00
None
320.48K
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$9.72M
3.73%
Sole
0.00
Shared
0.00
None
2.01M
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$7.95M
3.05%
Sole
0.00
Shared
0.00
None
8.06M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares126.63K
TypeSH
Market value$1.98M
0.76%
Sole
0.00
Shared
0.00
None
126.63K
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.48M
0.57%
Sole
0.00
Shared
0.00
None
1M
CERO THERAPEUTICS HOLDINGS, INC.
SOLEShares1.44M
TypeSH
Market value$134.8K
0.05%
Sole
0.00
Shared
0.00
None
1.44M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INC.SOLE | COM | 4.83M | SH | $118.45M 45.46% | 0.00 | 0.00 | 4.83M |
RAPPORT THERAPEUTICS, INC.SOLE | COM | 3.73M | SH | $76.36M 29.31% | 0.00 | 0.00 | 3.73M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $30.18M 11.58% | 0.00 | 0.00 | 11.06M |
Q32 BIO INC.SOLE | COM | 320.48K | SH | $14.30M 5.49% | 0.00 | 0.00 | 320.48K |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $9.72M 3.73% | 0.00 | 0.00 | 2.01M |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $7.95M 3.05% | 0.00 | 0.00 | 8.06M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM NEW | 126.63K | SH | $1.98M 0.76% | 0.00 | 0.00 | 126.63K |
UNITY BIOTECHNOLOGY, INC.SOLE | COM NEW | 1M | SH | $1.48M 0.57% | 0.00 | 0.00 | 1M |
CERO THERAPEUTICS HOLDINGS, INC.SOLE | CLASS A COM | 1.44M | SH | $134.8K 0.05% | 0.00 | 0.00 | 1.44M |